Evidence map›Paper›PMID 28184197›Full record

ArticleFrontiers in pharmacology2017

Therapeutic Efficacy of Esomeprazole in Cotton Smoke-Induced Lung Injury Model.

Christina Nelson, Jameisha Lee, Kang Ko, Andrew G Sikora, Mark D Bonnen, Perenlei Enkhbaatar, Yohannes T Ghebre

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Emerging therapies for smoke inhalation injury: a review.Journal of translational medicine · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Christina NelsonDepartment of Anesthesiology, University of Texas Medical Branch Galveston, TX, USA.
Jameisha LeeDepartment of Anesthesiology, University of Texas Medical Branch Galveston, TX, USA.
Kang KoDepartment of Anesthesiology, University of Texas Medical Branch Galveston, TX, USA.
Andrew G SikoraDepartment of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine Houston, TX, USA.
Mark D BonnenDepartment of Radiation Oncology, Baylor College of Medicine Houston, TX, USA.
Perenlei EnkhbaatarDepartment of Anesthesiology, University of Texas Medical Branch Galveston, TX, USA.
Yohannes T GhebreDepartment of Radiation Oncology, Baylor College of Medicine Houston, TX, USA.
The University of Texas Medical Branch at Galveston · USBaylor College of Medicine · US

Funding

DDAH As a Novel Target in Pulmonary FibrosisK01HL118683 · NHLBI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI GHEBRE, YOHANNES T · 2013 to 2017
$682k
NHLBI NIH HHS K01 HL118683
6 · The paper itself

Abstract

Proton pump inhibitors (PPIs) are well-known antacid drugs developed to treat gastric disorders. Emerging studies demonstrate that PPIs possess biological activities that extend beyond inhibition of H

Indexed as

fibrosisinflammationlung injuryproton pump inhibitors

Identifiers

PMID28184197
PMCPMC5266706
OpenAlexW2581288636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.